Tianzhu Lu

12PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 23, 2025
Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma.

Honghui Xie, Lin Zhang, Lizhi Chen

|Feb 24, 2025
Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study.

Yujun Hu, Tianzhu Lu, Hao Zhang

|Dec 11, 2023
Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma.

Tian-Zhu Lu, Fu-Juan Zeng, Yu-Jun Hu

|Nov 29, 2023
A Novel Prognostic Model Predicts Outcomes in Non-Metastatic Nasopharyngeal Carcinoma Based on Inflammation, Nutrition, and Coagulation Signature.

Li-Zhi Chen, Han-Shu Li, Gao-Wei Han

|Apr 24, 2023
Identification of immune-related genes contributing to head and neck squamous cell carcinoma development using weighted gene co-expression network analysis.

Qiaojuan Guo, Tianzhu Lu, Hanchuan Xu

|Sep 30, 2021
SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma.

Tianzhu Lu, Yiping Chen, Xiaochang Gong

Pageof 2

Frequent Collaborators

5 joint publications

Jianji Pan

3 joint publications

Qiaojuan Guo

2 joint publications

Lizhi Chen

2 joint publications

Jingao Li